Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014544218> ?p ?o ?g. }
- W3014544218 endingPage "146817" @default.
- W3014544218 startingPage "146817" @default.
- W3014544218 abstract "Hypoxic-ischemic encephalopathy (HIE) is an important cause of permanent damage to the central nervous system, associated with long-lasting neurological disabilities and neurodevelopmental impairment in neonates. Granulocyte-colony stimulating factor (G-CSF) has been shown to have neuroprotective activity in a variety of experimental brain injury models and G-CSF is a standard treatment in chemotherapeutic-induced neutropenia. The underlying mechanisms are still unclear. The mTOR (mammalian target of rapamycin) signaling pathway is a master regulator of cell growth and proliferation in the nervous system. However, the effects of G-CSF treatment on the mTOR signaling pathway have not been elucidated in neonates with hypoxic-ischemic (HI) brain injury. Our study investigated the neuroprotective effect of G-CSF on neonates with hypoxic-ischemic (HI) brain injury and the possible mechanism involving the mTOR/p70S6K pathway. Sprague-Dawley rat pups at postnatal day 7 (P7) were subjected to right unilateral carotid artery ligation followed by hypoxic (8% oxygen and balanced nitrogen) exposure for 2.5 h or sham surgery. Pups received normal saline, G-CSF, G-CSF combined with rapamycin or ethanol (vehicle for rapamycin) intraperitoneally. On postnatal day 9 (P9), TTC staining for infarct volume, and Nissl and TUNEL staining for neuronal cell injury were conducted. Activation of mTOR/p70S6K pathway, cleaved caspase-3 (CC3), Bax and Bcl-2 and cytokine expression levels were determined by western blotting. The G-CSF treated group was associated with significantly reduced infarction volume and decreased TUNEL positive neuronal cells compared to the HI group treated with saline. The expression levels of TNF-α and IL-1ß were significantly decreased in the G-CSF treated group, while IL-10 expression level was increased. The relative immunoreactivity of p-mTOR and p-p70S6K was significantly reduced in the HI group compared to sham. The HI group treated with G-CSF showed significant upregulated protein expression for p-mTOR and p-p70S6K levels compared to the HI group treated with saline. Furthermore, G-CSF treatment increased Bcl-2 expression levels and decreased CC3 and Bax expression levels in the ipsilateral hemispheres of the HI brain. The effects induced by G-CSF were all reversed by rapamycin. Treatment with G-CSF decreases inflammatory mediators and apoptotic factors, attenuating neuroinflammation and neuronal apoptosis via the mTOR/p70S6K signalling pathway, which represents a potential target for treating HI induced brain damage in neonatal HIE." @default.
- W3014544218 created "2020-04-10" @default.
- W3014544218 creator A5005228021 @default.
- W3014544218 creator A5024873810 @default.
- W3014544218 creator A5027834918 @default.
- W3014544218 creator A5035108007 @default.
- W3014544218 creator A5053675192 @default.
- W3014544218 creator A5074809215 @default.
- W3014544218 creator A5084864439 @default.
- W3014544218 creator A5087716778 @default.
- W3014544218 date "2020-07-01" @default.
- W3014544218 modified "2023-10-18" @default.
- W3014544218 title "G-CSF attenuates neuroinflammation and neuronal apoptosis via the mTOR/p70SK6 signaling pathway in neonatal Hypoxia-Ischemia rat model" @default.
- W3014544218 cites W1487068141 @default.
- W3014544218 cites W1522375197 @default.
- W3014544218 cites W1541003458 @default.
- W3014544218 cites W1605218324 @default.
- W3014544218 cites W1894556893 @default.
- W3014544218 cites W1971206035 @default.
- W3014544218 cites W1972748028 @default.
- W3014544218 cites W1974779129 @default.
- W3014544218 cites W1975499667 @default.
- W3014544218 cites W1981231759 @default.
- W3014544218 cites W1983074248 @default.
- W3014544218 cites W1986285940 @default.
- W3014544218 cites W1991950284 @default.
- W3014544218 cites W1992568202 @default.
- W3014544218 cites W1995197723 @default.
- W3014544218 cites W1997451049 @default.
- W3014544218 cites W1998821045 @default.
- W3014544218 cites W2003643542 @default.
- W3014544218 cites W2005853389 @default.
- W3014544218 cites W2008553918 @default.
- W3014544218 cites W2009449451 @default.
- W3014544218 cites W2009970281 @default.
- W3014544218 cites W2010247798 @default.
- W3014544218 cites W2016323277 @default.
- W3014544218 cites W2031655911 @default.
- W3014544218 cites W2039874371 @default.
- W3014544218 cites W2040957577 @default.
- W3014544218 cites W2042488504 @default.
- W3014544218 cites W2043217368 @default.
- W3014544218 cites W2048650878 @default.
- W3014544218 cites W2065056828 @default.
- W3014544218 cites W2066458888 @default.
- W3014544218 cites W2068112437 @default.
- W3014544218 cites W2070608780 @default.
- W3014544218 cites W2074142625 @default.
- W3014544218 cites W2075329507 @default.
- W3014544218 cites W2086680310 @default.
- W3014544218 cites W2089668713 @default.
- W3014544218 cites W2090326380 @default.
- W3014544218 cites W2098603695 @default.
- W3014544218 cites W2107261727 @default.
- W3014544218 cites W2111444310 @default.
- W3014544218 cites W2117863887 @default.
- W3014544218 cites W2123658895 @default.
- W3014544218 cites W2123851168 @default.
- W3014544218 cites W2126725112 @default.
- W3014544218 cites W2127063807 @default.
- W3014544218 cites W2131640859 @default.
- W3014544218 cites W2136967026 @default.
- W3014544218 cites W2170696359 @default.
- W3014544218 cites W2209403631 @default.
- W3014544218 cites W2231126270 @default.
- W3014544218 cites W2319831517 @default.
- W3014544218 cites W2522350841 @default.
- W3014544218 cites W2549132724 @default.
- W3014544218 cites W2553119477 @default.
- W3014544218 cites W2765179396 @default.
- W3014544218 cites W2779915244 @default.
- W3014544218 cites W987904007 @default.
- W3014544218 doi "https://doi.org/10.1016/j.brainres.2020.146817" @default.
- W3014544218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32246916" @default.
- W3014544218 hasPublicationYear "2020" @default.
- W3014544218 type Work @default.
- W3014544218 sameAs 3014544218 @default.
- W3014544218 citedByCount "16" @default.
- W3014544218 countsByYear W30145442182020 @default.
- W3014544218 countsByYear W30145442182021 @default.
- W3014544218 countsByYear W30145442182022 @default.
- W3014544218 countsByYear W30145442182023 @default.
- W3014544218 crossrefType "journal-article" @default.
- W3014544218 hasAuthorship W3014544218A5005228021 @default.
- W3014544218 hasAuthorship W3014544218A5024873810 @default.
- W3014544218 hasAuthorship W3014544218A5027834918 @default.
- W3014544218 hasAuthorship W3014544218A5035108007 @default.
- W3014544218 hasAuthorship W3014544218A5053675192 @default.
- W3014544218 hasAuthorship W3014544218A5074809215 @default.
- W3014544218 hasAuthorship W3014544218A5084864439 @default.
- W3014544218 hasAuthorship W3014544218A5087716778 @default.
- W3014544218 hasConcept C126322002 @default.
- W3014544218 hasConcept C134018914 @default.
- W3014544218 hasConcept C178790620 @default.
- W3014544218 hasConcept C185592680 @default.
- W3014544218 hasConcept C196795494 @default.
- W3014544218 hasConcept C204232928 @default.
- W3014544218 hasConcept C25498285 @default.